We reach patients in Europe through our own organisation, with a primary focus on non EU5 markets, and in particular Switzerland and Scandinavia
In 2015 the management team identified an opportunity in the value-added medicine space, and decided to enter with a global management team of senior executives, with a background in value-added medicine, branded medicine and generics.
In early 2016 Lopex Pharmaceuticals was formed in Switzerland and currently building up its organisation in Europe.
Lopex Pharmaceuticals is an innovative pharmaceutical company primarily focused on value-added medicine and devices.
We are providing business development services for pharma companies who want to launch products, looking for partners or establish an own business in Europe.
"We have a strong scientific foundation and optimize treatment paradigms to become a leading value-added medicine company."